This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Innovations by Youhei Ishida: Pioneering Carbapenem Derivatives
Introduction
Youhei Ishida is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, specifically through his work with carbapenem derivatives. His innovative approach has resulted in a noteworthy patent that underscores his expertise in antimicrobial agents.
Latest Patents
Youhei Ishida holds a patent for carbapenem derivatives characterized by a specific chemical formula. This innovation includes a range of components where (a) R₁ can be a hydrogen atom or an alkyl group ranging from 1 to 6 carbon atoms, (b) COOR₂ represents a carboxyl group or its protected form, (c) R₃ is also an alkyl group of 1 to 6 carbon atoms, and (d) R₄ is defined as a substitutable heterobicyclic group. These compounds are recognized for their potent and stable antimicrobial properties, significantly impacting the pharmaceutical landscape.
Career Highlights
Youhei Ishida's career has been marked by his association with Daiichi Pharmaceutical Co., Ltd., a leading company in the pharmaceutical sector. His dedication to research and development in antimicrobial agents has positioned him as an influential figure within the industry. The success of his patent reflects not only his individual creativity but also the ongoing commitment to advancing medical science.
Collaborations
Throughout his career, Youhei Ishida has collaborated with esteemed colleagues such as Makoto Takemura and Toshiyuki Nishi. Together, they have worked on various projects, enhancing the development of pharmaceutical innovations through shared expertise and teamwork.
Conclusion
Youhei Ishida is a vital contributor to the field of pharmaceuticals, particularly in the development of effective antimicrobial agents. His patent for carbapenem derivatives exemplifies the potential of innovative research in addressing critical health challenges. As he continues to work with Daiichi Pharmaceutical Co., Ltd. and his talented colleagues, there is no doubt that he will further influence the landscape of medical science in meaningful ways.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile